STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
YTEN YIELD10 BIOSCIENCE INCORPORATED StockScouter® Report
3
StockScouter® Score
YIELD10 BIOSCIENCE INCORPORATED, a micro cap growth company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Short-term relative price momentum exhibits moderate strength. Postive/Neutral
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- The multi-period measure of relative price change and consistency is well below average. Negative
- Moving average analysis for YTEN suggests weak price movement over the medium term. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
D
C
F
F